Actionnariat et activité des initiés pour Prothena Corporation plc (PRTA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $8.24 |
| Capitalisation | $431M |
| Bourse | NASDAQ |
| Pays | IE |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-02 | SCULLY WILLIAM P | P-Purchase | 27,000 | $256K |
| 2026-08-20 | SCULLY WILLIAM P | P-Purchase | 50,000 | $439K |
| 2026-08-18 | Fennell Todd W. | |||
| 2026-08-17 | SCULLY WILLIAM P | G-Gift | 336,000 | |
| 2026-08-18 | SCULLY WILLIAM P | G-Gift | 627,553 | |
| 2026-08-10 | SCULLY WILLIAM P | G-Gift | 251,553 | |
| 2026-08-06 | Fennell Todd W. | |||
| 2026-08-07 | SCULLY WILLIAM P | P-Purchase | 34,000 | $293K |
| 2026-08-07 | SCULLY WILLIAM P | P-Purchase | 3,500 | $30K |
| 2026-07-28 | Zago Wagner M. | M-Exempt | 51,000 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $386.9M | $417.6M | $427.7M | $375.7M | $295.4M | $579.1M | $710.4M | $618.8M | $471.4M | $307.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $178000 | $240000 | $2000 | $68000 | $15000 | $13000 | $62000 | $5.2M | 0 | 0 |
| Stocks | -$178000 | -$240000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $391.4M | $426.3M | $431.4M | $378.4M | $299.3M | $584.8M | $719.1M | $639.3M | $485.4M | $315.2M |
| Immobilisations Corporelles | $56.5M | $55.0M | $52.8M | $27.1M | $20.4M | $14.1M | $8.0M | $16.0M | $13.8M | $10.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $460.0M | $496.3M | $498.8M | $419.3M | $333.0M | $609.4M | $758.0M | $696.4M | $547.1M | $326.8M |
| Dettes Fournisseurs | $13.1M | $13.6M | $1.5M | $1.2M | $4.1M | $3.7M | $9.3M | $25.4M | $7.8M | $5.9M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.9M |
| Passifs Courants | $41.1M | $37.4M | $14.9M | $17.7M | $25.8M | $33.5M | $50.1M | $56.9M | $48.5M | $40.8M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.5M |
| Passifs Totaux | $94.6M | $89.1M | $175.8M | $146.3M | $149.0M | $143.3M | $136.0M | $135.0M | $60.2M | $46.3M |
| Réserves | -$289.2M | -$442.4M | -$598.0M | -$671.9M | -$783.0M | -$716.1M | -$833.0M | -$980.0M | -$1.10B | -$1.35B |
| Capitaux Propres | $365.4M | $407.2M | $323.0M | $272.9M | $184.0M | $466.0M | $622.0M | $561.4M | $486.9M | $280.5M |
| Dette Totale | $51.3M | $52.2M | $51.5M | $22.9M | $17.8M | $12.3M | $6.5M | $11.8M | $10.8M | $13.9M |
| Dette Nette | -$335.6M | -$365.4M | -$376.1M | -$352.8M | -$277.5M | -$566.8M | -$703.9M | -$607.0M | -$460.5M | -$293.7M |
| Fonds de Roulement | $350.3M | $389.0M | $416.5M | $360.7M | $273.4M | $551.4M | $669.0M | $582.4M | $436.9M | $274.4M |
Santé financière
| Dette / Capitaux propres | 0.02 |
| Ratio de liquidité | 25.05 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 0.06 |
Rentabilité
| Rentabilité des capitaux propres | -14.98% |
| Rentabilité du capital investi | -21.36% |
| Rentabilité des actifs | -14.54% |
| Marge brute | 43.52% |
| Marge opérationnelle | -115.09% |
| Marge nette | -80.67% |
Entreprises liées: BCYC · CRVS · FDMT · GOSS · KALV · NMRA · OLMA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PRTA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions